Featured

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

North America Session – From reaction to result: Connecting chemistry and biology for smarter drug discovery

A molecule passes through many hands in drug discovery. Medicinal chemists design and synthesise it, analytical scientists characterise it, and biology teams evaluate its activity. Yet the scientific knowledge generated along the way often remains fragmented across disconnected systems, making it difficult to connect what was made, how it was… Read More

Webinar date:
Supported by Benchling
#Featured Webinars #Webinars

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Europe Session – From reaction to result: Connecting chemistry and biology for smarter drug discovery

A molecule passes through many hands in drug discovery. Medicinal chemists design and synthesise it, analytical scientists characterise it, and biology teams evaluate its activity. Yet the scientific knowledge generated along the way often remains fragmented across disconnected systems, making it difficult to connect what was made, how it was… Read More

Webinar date:
Supported by Benchling
#Featured Webinars #Webinars

#Biomarkers #Drug discovery #Evotec #Immunoassays #Webinar

Measuring what matters: Applying ultrasensitive immunoassays for clinical biomarkers

When biomarkers are present at very low concentrations, conventional immunoassays may not provide the sensitivity needed to generate reliable, meaningful data. This can limit the ability to assess target engagement, monitor pharmacodynamic responses and track biomarker changes during treatment. Ultrasensitive immunoassays offer new opportunities to address these challenges. In this… Read More

Webinar date:
Supported by Evotec
#Featured Webinars #Webinars

#Crown Bioscience #Drug discovery #PDX models #Webinar

Beyond the model: Exploring warm PDX benefits and onsite expertise

Patient-derived xenograft (PDX) models are a valuable tool in oncology research, helping researchers evaluate therapeutic efficacy in preclinical settings using models that retain key characteristics of human tumours. In this webinar, Crown Bioscience will highlight the capabilities of its PDX model portfolio, with a particular focus on the benefits of… Read More

Webinar date:
Supported by Crown Bioscience
#Featured Webinars #Webinars

#Biomarkers #Drug discovery #Evotec #Webinar

From PK/PD and Biomarkers to decision-making: How modeling shapes clinical strategy

Clinical trials continue to experience high attrition rates, with lack of efficacy being one of the leading causes of failure. However, in many cases, these failures do not reflect a lack of drug efficacy, but rather limitations in translational biomarker strategies and selection of disease-relevant pharmacodynamic (PD) biomarkers, suboptimal dose… Read More

Webinar date:
Supported by Evotec
#Featured Webinars #Webinars

Cell and gene therapy
#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy

Advances and challenges in cell and gene therapies

Hosted by Drug Discovery World and supported by Bio-Techne, this webinar explores the advances and challenges taking place within the cell and gene therapy field. Hear from Hans Schambye CEO at BOOST Pharma, Lucas Arruda, CSO at CuraCell, and Brandon Cieniewicz, Director, Research & Development at CERo Therapeutics. Throughout the… Read More

Webinar date:
Sponsored by Bio-Techne
#Featured Webinars

Webinars

#AI / data analytics / healthtech / informatics #Biomarkers #Drug discovery #Personalised medicine #Webinar

Innovative AI software solutions driving biomarker research

Biomarker discovery and validation are critical for advancing personalised medicine and improving therapeutic outcomes. However, the complexity of high-throughput assays and image-based analyses presents significant challenges in extracting meaningful insights efficiently. This webinar, hosted by DDW and supported by Danaher Life Sciences, explores how advanced platforms such as Genedata Profiler… Read More

Webinar date:
Supported by Danaher
#Webinars

Structure of a molecule
#Drug discovery #Small molecules #Webinar

Quality drug candidates in under two years

Join this free webinar, hosted by DDW, to learn how Evotec is planning to shorten timelines for small molecule drug discovery projects. Using its ‘Every Compound a Candidate (ECC)’ approach, Evotec is aiming to reduce timelines to under two years. This webinar will explore the current challenges facing small molecule… Read More

Webinar date:
Supported by Evotec
#Webinars

#AI / data analytics / healthtech / informatics #Automation #Drug discovery #Organoids #Webinar

Standardising organoid workflows: How automation and AI enable reliable, scalable models

Organoids have emerged as powerful in vitro models in disease modelling, drug screening, and regenerative medicine, but their complexity introduces major workflow challenges, from culture variability to labour-intensive handling. This webinar, hosted by DDW and supported by Galatek, explores the evolving landscape of organoid research, identify common bottlenecks in daily… Read More

Webinar date:
Supported by Galatek
#Webinars

Molecules
#Drug design #Drug discovery #Structural biology #Webinar

Driving breakthroughs with structure-guided drug design

Hosted by Drug Discovery World and supported by Curia, this free webinar explores the use of protein X-ray crystallography in accelerating the drug design process. The first challenge in drug discovery is selecting a biological target and validating it as a ‘druggable’ binding site. The key to this is identifying… Read More

Webinar date:
Supported by Curia
#Webinars

Cell and gene therapy concept
#Advanced Therapies #Cell and gene therapy #Cell therapy #Gene therapy

Breaking barriers in cell and gene therapy

Hosted by Drug Discovery World and sponsored by Oxford Nanopore Technologies, this free webinar will explore developments in CGT drug discovery and development. You will hear from Brian Culley, CEO of Lineage Cell Therapeutics, Will Decker, CSO of Diakonos Oncology, and John Maher, Scientific Founder and CSO of Leucid Bio. Read More

Webinar date:
Supported by Oxford Nanopore Technologies
#Webinars

#Cancer research #Immunoassay #Oncology #PROTAC #Protein degradation

PROTAC-Mediated CDK2 degradation in oncology: Immunoassay tools for therapeutic discovery

In this webinar, hosted by DDW and supported by Revvity, Audrey Johnson, a scientist at Beantown Biotech, explores the innovative application of targeted protein degradation (TPD) in oncology research, with a specific focus on CDK2 degradation for potential cancer treatments. Johnson is joined during the Q&A by Rachel Mendes, Senior… Read More

Webinar date:
Supported by Revvity
#Webinars

#Events #Flow Cytometry #Single-cell analysis #Spatial biology

Beyond conventional: Using advanced spectral solutions to expand single cell and population analysis

As the fields of flow cytometry and spatial biology advance, researchers are uncovering exciting applications for the expanding data from their samples. Innovative reagents, fluidic and optical engineering, and advanced detection technologies significantly boost data speed, accuracy, and depth. However, challenges persist, particularly in analysing rare,… Read More

Webinar date:
Sponsored by Thermo Fisher Scientific
#Webinars

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning

Transforming drug discovery with AI and digital labs

In this FREE TO ATTEND webinar, hosted by DDW and supported by Sapio Sciences, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational methods, AI, and machine learning are revolutionising drug discovery. Dr Kumar highlights how Schrödinger’s physics-based simulations and Free Energy… Read More

Webinar date:
Supported by Sapio Sciences
#Webinars

Digital pathology
#Artificial intelligence (AI) #Biopharma #Computational chemistry #Events #Pathology

Rewiring drug development: The strategic power of pathology and AI for biopharma R&D

Digital pathology and AI are fundamentally transforming how biopharma companies discover, develop, and deliver life-changing medicines. As a result, today’s leaders aren’t debating whether to invest in digital pathology—they’re racing to scale it, unlocking faster breakthroughs, smarter clinical trials, and broader patient access to next-generation therapies. Organisations that move quickly… Read More

Webinar date:
Sponsored by Proscia
#Webinars

#Artificial intelligence (AI) #Drug discovery #Events

The impact of AI on drug discovery innovation

Hosted by Drug Discovery World and sponsored by Benchling, this free webinar explores the impact of AI on drug discovery innovation. The webinar sees AI experts and leaders discuss where innovation is occurring and what the challenges are to overcome in drug discovery and development. You will hear from Martin… Read More

Webinar date:
Sponsored by Benchling
#Webinars

#AAV #Gene therapy #Genomics #Nanopore sequencing

What’s in your gene therapy product? Rapid, comprehensive AAV genomic profiling made simple

As the field of gene therapy advances, the need for fast, accurate, and scalable characterisation of adeno-associated virus (AAV) products and the plasmids used to produce them has never been greater. Join Oxford Nanopore Technologies and Plasmidsaurus for an expert-led webinar, hosted by DDW, showcasing new and improved genomics solutions… Read More

Webinar date:
Supported by Oxford Nanopore Technologies
#Webinars

#Cancer research #Drug discovery #Events #Oncology

Unpacking the latest developments in cancer research

This free webinar, hosted by DDW and sponsored by Scale Biosciences, sees experts and thought-leaders from the cancer research sector discuss where innovation is occurring and what the challenges are to overcome for drug discovery projects in the oncology field. Presenters include Roy Maute, CEO and co-founder of Pheast Therapeutics,… Read More

Webinar date:
Sponsored by Scale Biosciences
#Webinars

#Drug discovery #Events #Neuroscience

Where is the innovation in neuroscience drug discovery?

This free webinar, hosted by DDW and sponsored by Emulate, sees experts and thought leaders from the neuroscience sector discuss where innovation is occurring and what the challenges are to overcome for drug discovery projects targeting neuroscience. You will learn: The challenges and opportunities in neuroscience drug discovery & development… Read More

Webinar date:
Sponsored by Emulate
#Webinars

#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening

Advancing high-throughput cardiac screening with physiologically relevant 3D iPSC-based models

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in high-throughput applications… Read More

Webinar date:
Supported by Ncardia
#Webinars

#Artificial intelligence (AI) #DDW Turning Science into Business Summit #Drug discovery #Events #Machine learning

‘Turning Science into Business’ AI & ML summit: Navigating AI-driven drug discovery

Watch the DDW ‘Turning Science into Business’ AI & ML summit: Navigating AI-driven drug discovery, to learn about the areas of opportunity for AI & ML in the drug discovery sector. The DDW ‘Turning Science into Business’ AI & ML summit sees experts and thought leaders in AI describe the… Read More

Webinar date:
Sponsored by The Jackson Laboratory
#Webinars

Ion channel modulators
#CNS #Drug discovery #Ion channel modulators #Therapeutic targets

Ion channel drug discovery – current trends and future opportunities

Ion channels are often regarded as ‘difficult’ drug discovery targets, but this webinar, hosted by DDW and supported by Axxam, provides data and insights showing that this negative perception is inaccurate and that there has been remarkable progress in bringing novel ion channel modulators into the clinic over the last… Read More

Webinar date:
Supported by Axxam
#Webinars